Serum neurofilament levels in patients with multiple sclerosis: A comparison of SIMOA and high sensitivity ELISA assays and contributing factors to ELISA levels

被引:18
作者
Revendova, K. Zondra [1 ,2 ]
Zeman, D. [3 ]
Bunganic, R. [1 ]
Karasova, K. [4 ]
Volny, O. [1 ,2 ]
Bar, M. [1 ,2 ]
Kusnierova, P. [4 ,5 ]
机构
[1] Univ Hosp Ostrava, Dept Neurol, Ostrava, Czech Republic
[2] Univ Ostrava, Dept Clin Neurosci, Ostrava, Czech Republic
[3] Univ Hosp Brno, Inst Lab Med, Brno, Czech Republic
[4] Univ Ostrava, Inst Lab Med, Ostrava, Czech Republic
[5] Univ Hosp Ostrava, Inst Lab Med, Dept Clin Biochem, Ostrava, Czech Republic
关键词
Neurofilament light chain; Neurofilament heavy chain; Multiple sclerosis; SIMOA; High sensitivity ELISA; LIGHT-CHAIN;
D O I
10.1016/j.msard.2022.104177
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Serum neurofilaments (sNfs), especially the most investigated serum neurofilament light chain (sNfL), are promising biomarkers in multiple sclerosis (MS). However, their clinical utility is still limited, given the availability and costs of accessible analytical methods. The gold standard for the detection of sNfs is rep-resented by the single molecule arrays (SIMOA). Recently, a high sensitivity enzyme-linked immunosorbent assay (hsELISA) has also been introduced. The objective of the study was to compare both assays for the determination of sNfL and neurofilament heavy chain (sNfH) concentrations in a defined MS cohort. The second objective was to identify contributing factors to sNfs concentrations determined by hsELISA.Methods: Serum samples were collected from MS patients attending the MS Centre, University Hospital Ostrava, Czech Republic. The levels of sNfs were detected using SIMOA and hsELISA assays. Results: The Spearman's rank correlation coefficient between the sNfL SIMOA and sNfL hsELISA and between the sNfH SIMOA and sNfH hsELISA was moderate rs= 0.543 (p = 0.001) and rs= 0.583 (p = 0.001), respectively. The Passing-Bablok regression analysis demonstrated bias between both methods. Equally significant bias between the methods was confirmed by the Bland-Altman plots. Furthermore, confounding factors affecting the sNfL levels were glomerular filtration rate (eGFR; 95% CI-2.34 to-0.04) and sex (95% CI-2.38 to-0.10). The sNfH levels were affected by age (95% CI 0.01 to 0.07), eGFR (95% CI-2.45 to-0.02), body mass index (BMI; 95% CI-0.31 to-0.05), and blood volume (95% CI 0.69 to 3.35).Conclusion: This analytical study showed significant differences between hsELISA and SIMOA methods, especially for the sNfH concentrations. We identified confounding factors for sNfs levels determined by hsELISA. The sNfs levels were influenced by renal function and sex, whilst sNfH levels were affected by age, BMI, and total blood volume.
引用
收藏
页数:6
相关论文
共 20 条
  • [1] Renal function is associated with blood neurofilament light chain level in older adults
    Akamine, Shoshin
    Marutani, Noriko
    Kanayama, Daisuke
    Gotoh, Shiho
    Maruyama, Riki
    Yanagida, Kanta
    Sakagami, Yukako
    Mori, Kohji
    Adachi, Hiroyoshi
    Kozawa, Junji
    Maeda, Norikazu
    Otsuki, Michio
    Matsuoka, Takaaki
    Iwahashi, Hiromi
    Shimomura, Iichiro
    Ikeda, Manabu
    Kudo, Takashi
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [2] Blood neurofilament light: a critical review of its application to neurologic disease
    Barro, Christian
    Chitnis, Tanuja
    Weiner, Howard L.
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (12): : 2508 - 2523
  • [3] The potential of serum neurofilament as biomarker for multiple sclerosis
    Bittner, Stefan
    Oh, Jiwon
    Havrdova, Eva Kubala
    Tintore, Mar
    Zipp, Frauke
    [J]. BRAIN, 2021, 144 : 2954 - 2963
  • [4] Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
    Bridel, Claire
    van Wieringen, Wessel N.
    Zetterberg, Henrik
    Tijms, Betty M.
    Teunissen, Charlotte E.
    Alvarez-Cermeno, Jose C.
    Andreasson, Ulf
    Axelsson, Markus
    Backstrom, David C.
    Bartos, Ales
    Bjerke, Maria
    Blennow, Kaj
    Boxer, Adam
    Brundin, Lou
    Burman, Joachim
    Christensen, Tove
    Fialova, Lenka
    Forsgren, Lars
    Frederiksen, Jette L.
    Gisslen, Magnus
    Gray, Elizabeth
    Gunnarsson, Martin
    Hall, Sara
    Hansson, Oskar
    Herbert, Megan K.
    Jakobsson, Joel
    Jessen-Krut, Jan
    Janelidze, Shorena
    Johannsson, Gudmundur
    Jonsson, Michael
    Kappos, Ludwig
    Khademi, Mohsen
    Khalil, Michael
    Kuhle, Jens
    Landen, Mikael
    Leinonen, Ville
    Logroscino, Giancarlo
    Lu, Ching-Hua
    Lycke, Jan
    Magdalinou, Nadia K.
    Malaspina, Andrea
    Mattsson, Niklas
    Meeter, Lieke H.
    Mehta, Sanjay R.
    Modvig, Signe
    Olsson, Tomas
    Paterson, Ross W.
    Perez-Santiago, Josue
    Piehl, Fredrik
    Pijnenburg, Yolande A. L.
    [J]. JAMA NEUROLOGY, 2019, 76 (09) : 1035 - 1048
  • [5] Analytical and pre-analytical aspects of neurofilament light chain determination in biological fluids
    Fialova, L.
    Noskova, L.
    Kalousova, M.
    Zima, T.
    Uher, T.
    Bartos, A.
    [J]. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2022, 85 (01) : 11 - 16
  • [6] Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients
    Gresle, M. M.
    Liu, Y.
    Dagley, L. F.
    Haartsen, J.
    Pearson, F.
    Purcell, A. W.
    Laverick, L.
    Petzold, A.
    Lucas, R. M.
    Van der Walt, A.
    Prime, H.
    Morris, D. R.
    Taylor, B. V.
    Shaw, G.
    Butzkueven, H.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (11) : 1209 - 1213
  • [7] Biological variation of serum neurofilament light chain
    Hviid, Claus Vinter Bodker
    Madsen, Anne Tranberg
    Winther-Larsen, Anne
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (04) : 569 - 575
  • [8] Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
    Kuhle, J.
    Leppert, D.
    Petzold, A.
    Regeniter, A.
    Schindler, C.
    Mehling, M.
    Anthony, D. C.
    Kappos, L.
    Lindberg, R. L. P.
    [J]. NEUROLOGY, 2011, 76 (14) : 1206 - 1213
  • [9] Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
    Kuhle, Jens
    Barro, Christian
    Andreasson, Ulf
    Derfuss, Tobias
    Lindberg, Raija
    Sandelius, Asa
    Liman, Victor
    Norgren, Niklas
    Blennow, Kaj
    Zetterberg, Henrik
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (10) : 1655 - 1661
  • [10] Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
    Kusnierova, Pavlina
    Zeman, David
    Hradilek, Pavel
    Cabal, Martin
    Zapletalova, Olga
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (07)